Head-to-Head

Eli Lilly & Co. vs. Phibro Animal Health Corporation Class A

LLY

Eli Lilly & Co.

$1184.83 +0.12%

VS PAHC

Phibro Animal Health Corporation Class A

$35.99 +4.47%

Phibro Animal Health Corporation Class A (PAHC) comes out ahead, leading on 2 of 3 compared factors.

Size & Scale

LLYPAHC
Market Cap $1.05 trillion $1.40 billion
Revenue (TTM) $79.67 billion —
Net Income (TTM) $26.71 billion —

LLY leads on 1 of 1 size & scale factors.

Valuation

LLYPAHC
P/E Ratio 39.77 —
Price / Book 31.14 —
Price / Sales 13.24 —

LLY and PAHC split the valuation factors evenly.

Profitability

LLYPAHC
Net Margin 33.53% —
Return on Equity 78.84% —

LLY and PAHC split the profitability factors evenly.

Dividend

LLYPAHC
Dividend Yield 0.58% 1.33%
Payout Ratio 23.23 —

PAHC leads on 1 of 1 dividend factors.

Risk & Sentiment

LLYPAHC
Short Interest 1.29% 0.85%

PAHC leads on 1 of 1 risk & sentiment factors.

Dig deeper: LLY overview, LLY financials, PAHC overview, PAHC financials.

Comparisons use delayed, cached fundamental data and cover only the factors shown. For informational purposes only — not investment advice.